The public docket on proposed recommendations for developing continuous manufacturing of solid dosage drugs includes 24 submissions by industry stakeholders. “A high priority for new guidance should be on the harmonization of terms and definitions relating to continuous manufacturing, GSK said, encouraging “the consistent use of terminology in existing guidances and the non-proliferation of new terms.” Similarly, the ECA Foundation recommends involving “organizations which can support harmonization such as PIC/S and/or ICH at a very early stage.”
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
